Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma

References

• Bast, Jr., R.C., Feeney, M., Lazarus, H., Nadler, L.M., Clovin, R.B. and Knapp, B.C. (1981) "Reactivity of a monoclonal antibody with human ovarian carcinoma", Journal of Clinical Investigation 68, 1331–1337.
   PubMed Web of Science ®Google Scholar
• Bischof, P. (1993) "What do we know about the origin of CA 125?", European Journal of Obstetrics Gynecology Reproductive Biology 49, 93–98.
   PubMed Web of Science ®Google Scholar
• Bast, R.C., Jr., Klug, T.L., St. John, E., Jenison, E., Niloff, J.M., Lazarus, H., Berkowitz, R.S., Leavitt, T., Griffiths, CT., Parker, L., Zurawski, V.R. and Knapp, R.C. (1983) "A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer", New England Journal of Medicine 309, 883–887.
   PubMed Web of Science ®Google Scholar
• Zeillemaker, A.M., Verbrugh, HA., Hoynck van Papendrecht, A.A.G.M. and Leguit, P. (1994) "CA 125 secretion by peritoneal mesothelial cells", Journal of Clinical Pathology 47, 263–265.
   PubMed Web of Science ®Google Scholar
• Halila, H., Stenman, U.H. and Seppala, M. (1986) "Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy", Cancer 57, 1327–1329.
   PubMed Web of Science ®Google Scholar
• Bergmann, J.F., Bidart, J.M., George, M., Beaugrand, M., Levy, V.G. and Bohuon, C. (1987) "Elevation of CA 125 in patients with benign and malignant ascites", Cancer 59, 213–217.
   PubMed Web of Science ®Google Scholar
• Grankvist, K., Ljungberg, B. and Rasmuson, T. (1997) "Evaluation of five glycoprotein tumor markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for prognosis of renal-cell carcinoma", International Journal of Cancer 74, 233–236.
   PubMed Web of Science ®Google Scholar
• Salgia, R., Harpole, D., Herndon, J.E., Pisick, E., Elias, A. and Skarin, A.T. (2001) "Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer", Anticancer Research 21, 1241–1246.
   PubMed Web of Science ®Google Scholar
• Norum, L.F., Erikstein, B. and Nustad, K. (2001) "Elevated CA125 in breast cancer-A sigh of advanced disease", Tumour Biology 22, 223–228.
   PubMed Web of Science ®Google Scholar
• Nakata, B., Hirakawa-S Chung, K., Kato, Y, Yamashita, Y, Maeda, K., Onoda, N., Sawada, T. and Sowa, M. (1998) "Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma", Cancer 83, 2488–2492.
   Google Scholar
• Spitzer, M., Kaushal, N. and Benjamin, F. (1998) "Maternal CA125 levels in pregnancy and the puerperium", Journal of Reproductive Medicine 43, 387–392.
   PubMed Web of Science ®Google Scholar
• Zamir, D., Jarchovsky, J., Singer, C. and Weiner, P. (1998) "Elevated ovarian cancer marker (CA-125) in cirrhotic patients with intractable ascites", Journal of Clinical Gastroenterology 27, 154–155.
   PubMed Web of Science ®Google Scholar
• Sevinc, A., Buyukberber, S., Sari, R., Kiroglu, Y, Turk, H.M. and Ates, M. (2000) "Elevated serum CA-125 levels in hemodialysis patients with peritoneal, or pericardial fluids", Gynecology—Oncology 77, 254–257.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, CD. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airline House, Virginia, November 1997", Journal of Clinical Oncology 17, 3835–3849.
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factor Project(1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Topalak, 0., Saygili, U., Soyturk, M., Karanca, N., Batur, Y, Uslu, T. and Erten, 0. (2002) "Serum, pleural effusion and ascites CA 125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study", Gynecology—Oncology 85, 108–113.
   Google Scholar
• Apel, R.L. and Fernandes, B.J. (1995) "Malignant lymphoma presenting with an elevated serum CA 125 level", Archives Pathology and Laboratory Medicine 119, 373–376.
   PubMed Web of Science ®Google Scholar
• Pabst, T. and Ludwig, C. (1995) "CA 125: a tumor marker in non-Hodgkin's lymphoma?", Journal of Clinical Oncology 13, 1827 —1828.
   PubMed Web of Science ®Google Scholar
• Ravoet, C., Dargent, J.L., Le Moine, F. and Feremans, W. (1995) "CA 125 in primary mediastinal B-cell lymphoma with sclerosis", Journal of Clinical Oncology 13, 530, Letter.
   Google Scholar
• Sebban, C., Lasne, Y. and Berenguer, V. (1991) "CA 125 and malignant lymphomas", Journal of Clinical Oncology 9, 359–360, Letter.
   Google Scholar
• Benboubker, L., Valat, C., Linassier, C., Carton, G., Delain, M., Bout, M., Fetissof, F., Lefranq, T., Lamagnere, J.P. and Colombat, P. (2000) "A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA 125 and LDH serum levels", Annual of Oncology 11, 1485–1491.
   PubMed Web of Science ®Google Scholar
• Fehm, T., Beck, E., Valerius, T., Gramatzki, M. and Jager, W. (1998) "CA 125 elevation in patients with malignant lymphomas", Tumour Biology 19, 283–289.
   PubMed Web of Science ®Google Scholar
• Lazzarino, M., Orlandi, E., Klersy, C., Astori, C., Brusamolino, E., Corso, A., Bellio, L., Gargantini, L., Mona, E. and Bernasconi, C. (1998) "Serum CA125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity", Cancer 82, 576–582.
   PubMed Web of Science ®Google Scholar
• Ozguroglu, M., Turna, H., Demir, G., Doventas, A., Demirelli, F., Mandel, N.M., Buyukunal, E., Serdengecti, S. and Berkarda, B. (1999) "Usefulness of the epithelial tumor marker CA 125 in non-Hodgkin's lymphoma", American Journal of Clinical Oncology 22, 615–618.
   PubMed Web of Science ®Google Scholar
• Hu, Y, Thong, A. and Yang, X. (2000) "Prognostic value of serum CA 125 level in patients with advanced non-small cell lung cancer", Zhonghua Zhong Liu Za Zhi 22, 30–31.
   PubMedGoogle Scholar
• Hatzalds, K.D., Froudarakis, ME., Bouros, D., Tzanalds, N., Karkavitsas, N. and Siafakas, N.M. (2002) "Prognostic value of serum tumor markers in patients with lung cancer", Respiration 69, 25–29.
   PubMed Web of Science ®Google Scholar
• Bold, R.J., Ota, D.M., Ajani, J.A. and Mansfield, P.F. (1999) "Peritoneal and serum tumor markers predict recurrence and survival of patients with respectable gastric cancer", Gastric Cancer 2, 1–7.
   PubMedGoogle Scholar
• Lundstrom, MS., Hogdall, C.K., Nielsen, A.L. and Nyholm, H.C. (2000) "Serum tetranectin and CA 125 in endometrial adenocarci-noma", Anticancer Research 20, 3903–3906.
   PubMed Web of Science ®Google Scholar
• Xie, Z., Zhang, J. and Tan, A. (2001) "Relationship between serum CA 125 level and prognosis in the patients with uterine endometrial carcinoma", Zhonghua 1i Xue Za Zhi 81, 1456–1457.
   Google Scholar